Enwei Pharmaceutical Co., Ltd. (SHE:301331)
23.56
+0.12 (0.51%)
At close: Jul 3, 2026
-27.06% (1Y)
| Market Cap | 2.40B -13.4% |
| Revenue (ttm) | 879.60M +6.6% |
| Net Income | 48.14M +6.1% |
| EPS | 0.46 +2.7% |
| Shares Out | 101.88M |
| PE Ratio | 50.82 |
| Forward PE | n/a |
| Dividend | 0.66 (2.80%) |
| Ex-Dividend Date | May 28, 2026 |
| Volume | 1,852,285 |
| Open | 23.26 |
| Previous Close | 23.44 |
| Day's Range | 23.15 - 23.78 |
| 52-Week Range | 20.56 - 39.66 |
| Beta | 0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 27, 2026 |